JPWO2025154692A5 - - Google Patents

Info

Publication number
JPWO2025154692A5
JPWO2025154692A5 JP2025544453A JP2025544453A JPWO2025154692A5 JP WO2025154692 A5 JPWO2025154692 A5 JP WO2025154692A5 JP 2025544453 A JP2025544453 A JP 2025544453A JP 2025544453 A JP2025544453 A JP 2025544453A JP WO2025154692 A5 JPWO2025154692 A5 JP WO2025154692A5
Authority
JP
Japan
Prior art keywords
composition
formula
group
ch2ch2n
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025544453A
Other languages
English (en)
Japanese (ja)
Other versions
JP7765027B1 (ja
JPWO2025154692A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2025/000770 external-priority patent/WO2025154692A1/ja
Publication of JPWO2025154692A1 publication Critical patent/JPWO2025154692A1/ja
Application granted granted Critical
Publication of JP7765027B1 publication Critical patent/JP7765027B1/ja
Publication of JPWO2025154692A5 publication Critical patent/JPWO2025154692A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025544453A 2024-01-15 2025-01-14 アルツハイマー病予防若しくは治療用組成物 Active JP7765027B1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2024003975 2024-01-15
JP2024003975 2024-01-15
PCT/JP2025/000770 WO2025154692A1 (ja) 2024-01-15 2025-01-14 アルツハイマー病予防若しくは治療用組成物

Publications (3)

Publication Number Publication Date
JPWO2025154692A1 JPWO2025154692A1 (cg-RX-API-DMAC7.html) 2025-07-24
JP7765027B1 JP7765027B1 (ja) 2025-11-06
JPWO2025154692A5 true JPWO2025154692A5 (cg-RX-API-DMAC7.html) 2025-12-16

Family

ID=96471267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025544453A Active JP7765027B1 (ja) 2024-01-15 2025-01-14 アルツハイマー病予防若しくは治療用組成物

Country Status (3)

Country Link
JP (1) JP7765027B1 (cg-RX-API-DMAC7.html)
TW (1) TW202539627A (cg-RX-API-DMAC7.html)
WO (1) WO2025154692A1 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101787618B1 (ko) * 2010-09-24 2017-10-18 후지노 브레인 리서치 가부시키가이샤 항중추신경계 염증제

Similar Documents

Publication Publication Date Title
JP2024518554A5 (cg-RX-API-DMAC7.html)
JP2022512482A5 (cg-RX-API-DMAC7.html)
UY28878A1 (es) Compuestos de aril-o heteroarilamida ortosustituidos y composiciones
JP2009525302A5 (cg-RX-API-DMAC7.html)
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
ATE530066T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
JP2007517846A5 (cg-RX-API-DMAC7.html)
JP2024149717A5 (cg-RX-API-DMAC7.html)
JP2009532453A5 (cg-RX-API-DMAC7.html)
JP2007526331A5 (cg-RX-API-DMAC7.html)
RU2010145171A (ru) Аналоги галихондрина в
JP2013512277A5 (cg-RX-API-DMAC7.html)
JP2009541224A5 (cg-RX-API-DMAC7.html)
KR960022553A (ko) 신규한 에리스로마이신 유도체, 그의 제조 방법 및 의약으로서의 용도
JP2023543254A5 (cg-RX-API-DMAC7.html)
BRPI0409469A (pt) compostos para o tratamento de distúrbios metabólicos
JP2022537140A5 (cg-RX-API-DMAC7.html)
JP2021515755A5 (cg-RX-API-DMAC7.html)
JP2024534420A5 (cg-RX-API-DMAC7.html)
JP2010514734A5 (cg-RX-API-DMAC7.html)
JPWO2021187531A5 (cg-RX-API-DMAC7.html)
JPWO2025154692A5 (cg-RX-API-DMAC7.html)
JP2021532183A5 (cg-RX-API-DMAC7.html)
JP2024534633A5 (cg-RX-API-DMAC7.html)
JP2023061920A5 (cg-RX-API-DMAC7.html)